Neochem Bio Solutions (NSE:NEOCHEM) Notes Receivable: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:NEOCHEM Neochem Bio Solutions Ltd NSE:NEOCHEM
18 GF Score
Price ₹91.00
! 2 Warning Signs
View Full Analysis

What is Neochem Bio Solutions Notes Receivable?

Neochem Bio Solutions NSE:NEOCHEM +2.42% 18 Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:NEOCHEM with a GF Score™ of 18/100. The stock has 2 warning signs investors should review.

Neochem Bio Solutions's Notes Receivable for the quarter that ended in Mar. 2026 was ₹0 Mil.

Neochem Bio Solutions Notes Receivable Related Terms

Neochem Bio Solutions Notes Receivable Historical Data

* Premium members only.

The historical data trend for Neochem Bio Solutions's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neochem Bio Solutions Notes Receivable Chart

Neochem Bio Solutions Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Notes Receivable
0.00 0.00 0.00 0.00

Neochem Bio Solutions Semi-Annual Data
Mar23 Mar24 Mar25 Sep25 Mar26
Notes Receivable 0.00 0.00 0.00 0.00 0.00
NSE:NEOCHEM
18GF Score
Neochem Bio Solutions Ltd NSE:NEOCHEM
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neochem Bio Solutions Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0 Mil mean?
Neochem Bio Solutions (NSE:NEOCHEM) has a Notes Receivable of ₹0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Neochem Bio Solutions and its competitors.
Is Neochem Bio Solutions' Notes Receivable too high?
Neochem Bio Solutions' current Notes Receivable is ₹0 Mil. Overall, Neochem Bio Solutions has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Neochem Bio Solutions' Notes Receivable compare to LIN and SHW?
Neochem Bio Solutions' Notes Receivable of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Chemicals company?
A good Notes Receivable depends on the Chemicals industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Neochem Bio Solutions and its competitors. Neochem Bio Solutions's current Notes Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neochem Bio Solutions stock overvalued right now?
Neochem Bio Solutions (NSE:NEOCHEM) has a current Notes Receivable of ₹0 Mil. The current Notes Receivable is ₹0 Mil. Neochem Bio Solutions' overall GF Score™ is 18/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Neochem Bio Solutions (NSE:NEOCHEM), the current Notes Receivable is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neochem Bio Solutions Business Description

Address Iscon Ambli Road, 303, W1, Opposite Vikramnagar Colony office, Daskroi, Ahmedabad, GJ, IND, 380058
Neochem Bio Solutions Ltd is a specialty performance chemical company. Its primary product segments such as Polymers, Surfactants, Silicones, and Esters & bio-based sustainable solutions. The products are essential and used in industries such as textile & garment washing, home & personal care (HPC), institutional and industrial cleaners, water treatment, paints and coatings, paper and pulp, construction, rubber and dyes and pigments.
18GF Score

Get the complete analysis for NSE:NEOCHEM

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹91.00
Price